Q-TIME
14.15 – 14.45 Junior Professional Q-Time
The session consists of 6 presentations, 5-minutes each (3-minute presentation and 2-minute discussion).
14.15 – 14.20
Trajectory of lower airway bacterial colonization in pediatric and adult patients with primary ciliary dyskinesia Douvry Benoit (France)
14.20 – 14.25
Prevalence and clinical implications of CFTR Variants in people with Bronchiectasis Elisa Canella (Italy)
14.25 – 14.30
Reversibility of chronic bronchial dilatation in cystic fibrosis patients undergoing Elexacaftor/Tezacaftor/Ivacaftor: identification and prediction with deep learning Gael Dournes (France)
14.30 – 14.35
Continuous Cough Monitoring as a Biomarker for Bronchiectasis Therapy Assessment Mindaugas Galvosas (USA)
14.35 – 14.40
CC16 as a biomarker of bronchial infection and disease severity in bronchiectasis Lidia Perea (Spain)
14.40 – 14.45
Index of Multiple Deprivation, Bronchiectasis Severity Index and Pseudomonas Colonization Status Henil Upadhyay (India)